2015
DOI: 10.1080/19490976.2015.1024918
|View full text |Cite
|
Sign up to set email alerts
|

Type 2 diabetes and gut microbiome: at the intersection of known and unknown

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
59
0
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(64 citation statements)
references
References 52 publications
3
59
0
2
Order By: Relevance
“…Also, the findings suggest that core taxa constitute more than 75% of the gut and oral microbiome, while only 67% of the skin microbiome, indicating a larger variability of the microbiome present on the skin. We present baseline data of the human microbiome from a healthy Indian sub-population, which could be used as a reference for further studies, including diabetes [75][76][77] obesity and inflammatory diseases. (2020) 10:5685 | https://doi.org/10.1038/s41598-020-62195-5 www.nature.com/scientificreports www.nature.com/scientificreports/ Methods ethical clearance declaration.…”
Section: Discussionmentioning
confidence: 99%
“…Also, the findings suggest that core taxa constitute more than 75% of the gut and oral microbiome, while only 67% of the skin microbiome, indicating a larger variability of the microbiome present on the skin. We present baseline data of the human microbiome from a healthy Indian sub-population, which could be used as a reference for further studies, including diabetes [75][76][77] obesity and inflammatory diseases. (2020) 10:5685 | https://doi.org/10.1038/s41598-020-62195-5 www.nature.com/scientificreports www.nature.com/scientificreports/ Methods ethical clearance declaration.…”
Section: Discussionmentioning
confidence: 99%
“…Given that oxyntomodulin is a proglucagon derivative and co-localized with GLP-1 and GLP-2 in the L cells, it is possible that decreased oxyntomodulin and CGRP levels, as well as elevated levels of pro-inflammatory cytokines (57), may act as early indicators of a gut barrier dysfunction-associated chronic hyperglycemia. Although no clinical study to date has investigated the association between gut barrier function and diabetes of the exocrine pancreas, significant association between insulin resistance, HbA1c, fasting blood glucose and gut microbiota has been reported in clinical studies involving type 2 diabetes patients (60,63,64). Prebiotics, shown to improve glucose homeostasis, gut permeability, endotoxinaemia, inflammation, body weight, fat mass accumulation, and lipid metabolism-all associated with and implicated in the pathogenesis of acute pancreatitis, also induce changes in circulating levels of GLP-1, GIP, ghrelin, and peptide YY (65,66).…”
Section: Discussionmentioning
confidence: 99%
“…2 Compositional and metabolic changes in the intestinal microbiota (dysbiosis) have been found in association with inflammatory bowel disease, where there are increases in Proteobacteria, Firmicutes bacillus, and Actinobacteria. 3 Dysbiosis has also been implicated in the pathophysiology of colorectal cancer, multiple sclerosis, diabetes mellitus, obesity and allergies, [4][5][6][7][8] and most recently by us in sickle cell disease. 9 In addition to changing the intestinal microbiome, some antibiotics, like tetracyclines, fluoroquinolones and macrolides, also have intrinsic anti-inflammatory effects on the hosts.…”
Section: Introductionmentioning
confidence: 99%